Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-analgesic Effects of Sufentanil, Hydromorphone, and Oxycodone
NCT04396587Phase 4Completed
- Sponsor
- Peking University People's Hospital
- Start
- May 2020
- Primary completion
- Jan 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of sufentanil, hydromorphone, oxycodone in pain, sponsored by Peking University People's Hospital. Started May 2020; status: completed.
02
Drugs
sufentanilhydromorphoneoxycodone
03
Conditions
pain
Beyond the preview
Go deeper on NCT04396587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04396587.